Niagen Bioscience Inc (NAGE)

EBITDA

$18.32M

TTM · Period ending: · USD

NAGE logo

NAGE EBITDA

Latest reported$18.32M
NAGE EBITDA (-$38.38K → $18.32M)
High-resolution chart · PNG

NAGE ebitda history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Niagen Bioscience Inc EBITDA — Annual fiscal periods (USD)
Period endingEBITDA (USD)
19,642,000
10,339,000
-3,233,000
-14,656,000
-25,447,000
-18,341,000
-29,777,000
-32,330,000
-15,661,000
-2,485,650
-1,735,545
-4,971,026
-4,115,488
-11,289,387
-7,463,961
-1,629,741
-498,232
-1,687,723
-38,382
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.